Concentrated Stock Diversification for UHNW Investors
Not tax or legal advice. Verify all figures and strategies with qualified tax counsel before acting.
A $50M concentrated position in a single stock creates a problem that is genuinely different from what mainstream financial planning addresses. The tax cost of selling is real — 23.8% federal LTCG plus state tax — but so is the risk of doing nothing. Concentrated single-stock exposure has ended more $30M+ fortunes than any market downturn.
This guide covers the strategies available at the $30M+ level: exchange funds, prepaid variable forwards, CRT giving, DAF timing, QSBS optimization, and direct indexing. Each has a different risk/cost/control tradeoff. The right answer depends on your holding period, tax basis, liquidity need, philanthropic intent, and estate planning goals.
The tax math of a concentrated position
Suppose you hold $50M in a single stock acquired at near-zero basis — a common situation for founders post-exit or early employees of a company that IPO'd. If you sell outright today:
- Federal LTCG: 20% on $50M = $10,000,0001
- Federal NIIT (3.8% on net investment income above $250K MFJ): 3.8% × $50M ≈ $1,900,0002
- State capital gains tax (California example at 13.3%): $6,650,000
- Total federal + CA tax: ~$18.55M on a $50M gain
That leaves you with roughly $31M after tax — and a fully diversified portfolio. The question every UHNW holder faces: is the diversification worth the $18M cost? And are there ways to achieve most of the diversification at a lower tax price?
Exchange funds — defer via §721
An exchange fund is a private investment partnership that allows you to contribute appreciated stock in exchange for a pro-rata interest in a diversified portfolio — without triggering capital gains tax at the time of contribution. The legal basis is IRC §721, which provides that no gain or loss is recognized on a contribution of property to a partnership in exchange for a partnership interest.3
How it works: Ten to thirty investors, each holding a different concentrated stock, each contribute their position to the fund. You receive fund units representing a diversified basket of all contributed stocks. Your cost basis carries over from your original shares. After a required holding period, you can withdraw a diversified basket of positions, still deferring the gain until you eventually sell the individual holdings.
Key requirements and constraints:
- 7-year lockup. The partnership must hold your contributed shares for at least seven years before you can withdraw. Liquidity is restricted during this window.4
- 20% illiquid asset requirement. At least 20% of the fund's assets must be allocated to qualifying illiquid assets (typically real estate) to satisfy the tax code's requirements distinguishing this from a taxable exchange.
- Minimum investment. Most institutional exchange fund providers require $500,000 to $5,000,000 per contributed position. Newer technology-enabled platforms have lowered minimums to $100,000+, but institutional-quality funds for UHNW typically require $1M+ per contribution.
- Stock eligibility. Your stock must be publicly traded (or recently traded) and meet the fund's diversification standards. Thinly-traded small caps may not qualify. Pre-IPO stock is generally not eligible.
- Basis carries over. When you eventually sell or distribute positions, you pay tax on the full gain from the original cost basis. The exchange fund defers — it does not eliminate — the tax liability.
Best for: Investors who want to diversify a highly appreciated public stock position and do not need liquidity for 7+ years, have no strong charitable intent, and want a solution that is administratively straightforward compared to more complex derivative structures.
Prepaid variable forward — monetize with deferred tax
A prepaid variable forward (PVF) is a derivative contract with a financial institution that lets you receive immediate cash — typically 70–90% of your stock's current value — in exchange for a commitment to deliver a variable number of shares at a future date (usually 3–5 years out).5
Tax treatment: Under IRS Revenue Ruling 2003-7, gain on the underlying shares is not recognized until you actually deliver shares at settlement. The prepayment is treated as a loan, not a sale. This allows you to access substantial liquidity today while deferring capital gains recognition to the settlement date.5
How the variable delivery works: The contract specifies a floor and ceiling price for the stock. If the stock falls, you deliver more shares; if it rises, you deliver fewer. This structure gives you downside protection (a floor) while capping some upside — effectively hedging the concentrated position without a triggering a current taxable sale.
Important constraints:
- Constructive sale risk. A PVF that fully eliminates economic risk can be recharacterized as a constructive sale under IRC §1259, triggering immediate gain recognition. The variable delivery structure and retained upside participation are specifically designed to avoid this outcome, but the line is technical and must be drawn by qualified counsel.6
- Extension risk. Tax Court has held that extending a PVF contract beyond its original term can constitute a taxable event. Do not extend without a tax opinion.5
- Interest cost. The prepayment creates an implicit borrowing cost. At a 5% carry cost over 3 years on a $20M advance, you pay roughly $3M in implicit interest — worth modeling against the deferred tax benefit.
Best for: Investors who need liquidity now (e.g., to fund another venture, buy real estate, or reallocate), can tolerate some remaining stock exposure during the contract period, and want to defer gain recognition by 3–5 years, potentially into lower-income years (retirement, relocation, etc.).
Charitable remainder trust with appreciated stock — income + deduction
A charitable remainder trust (CRT) allows you to contribute appreciated stock to an irrevocable trust, receive an income stream for life or a term of years, and leave the remainder to charity — while taking a partial income tax deduction at contribution and avoiding immediate capital gains tax on the contributed position.7
The tax mechanics:
- The CRT sells your appreciated stock inside the trust, paying no capital gains tax at the trust level. The proceeds are reinvested in a diversified portfolio that funds your income stream.
- You receive an income tax deduction for the present value of the charitable remainder interest — calculated using IRS actuarial tables and the § 7520 rate at funding.
- Your income stream is taxed as you receive it, in a specific ordering (ordinary income, then capital gains, then return of principal) — not as a lump sum.
Deduction limits: For contributions of long-term appreciated property to a CRT, the income tax deduction is limited to 30% of adjusted gross income in the contribution year, with a 5-year carryforward for any unused deduction.7
Example: Contribute $5M of stock (near-zero basis) to a CRUT with a 5% annual payout, funded when the §7520 rate is 4.8%. Depending on your age, the charitable remainder deduction might be $1.5–2M. The CRT sells the stock, reinvests $5M tax-free, and pays you $250K/year. The $1.5M deduction offsets $1.5M of other income at your marginal rate (37% federal) — saving ~$555,000 in taxes. Meanwhile the $5M grows fully invested instead of the $3.8M that would remain after a full taxable sale.
Best for: Investors with strong philanthropic intent who want income, a tax deduction, and diversification. Not suitable for investors who want heirs (rather than charity) to receive the residual value — a CRT benefits charity at the end, not your estate.
DAF timing — maximize the charitable offset at the moment of sale
For founders in the middle of an M&A transaction or secondary sale, the most powerful move is often the simplest: contribute a portion of your position to a donor-advised fund (DAF) before the close.
If you contribute $3M of appreciated stock to a DAF prior to a company sale, you receive a charitable deduction equal to the stock's fair market value at the time of contribution — typically the per-share price implied by the transaction. The DAF then sells (or holds) the stock inside the fund with no capital gains tax. You avoid the 23.8%+ LTCG on the contributed shares entirely.
Timing is critical: The IRS scrutinizes contributions made after a sale is legally binding. To protect the deduction, the contribution should occur before the transaction closes — ideally before the company signs the definitive agreement or while the stock is publicly tradeable. Work with M&A counsel and your tax advisor on the exact timing.
DAF deduction limits: Publicly traded stock contributed to a DAF is deductible at fair market value, subject to the 30% of AGI limit (same as CRT). Private company stock is generally deductible at fair market value if supported by a qualified appraisal, but the IRS scrutiny is higher on pre-liquidity private stock valuations.
QSBS §1202 — founders with eligible C-corp shares
If you are a founder or early employee who held qualified small business stock (QSBS) under IRC §1202, the most tax-efficient outcome is to qualify for the exclusion entirely before considering any diversification strategy.
Under the One Big Beautiful Bill Act (OBBBA, July 2025), the §1202 exclusion was permanently raised to $15,000,000 per issuer with a tiered holding period requirement:8
- 3-year hold: 50% exclusion (up to $15M gain)
- 4-year hold: 75% exclusion (up to $15M gain)
- 5-year hold: 100% exclusion (up to $15M gain)
On a $15M qualifying gain with a 5-year hold, the federal capital gains tax is $0. At the UHNW level where a single exit can generate $30M+ in QSBS gain, this means the first $15M per issuer is potentially fully excludable — and if you hold shares in multiple entities (common for serial founders), each issuer's exclusion is independent.
Important QSBS eligibility requirements: The shares must be original-issue C-corp stock acquired at original issuance (not secondary); the company must have had gross assets of $50M or less at the time of issuance; and the company must be an active business in a qualifying industry (software, technology, and most professional services qualify; hotels, finance, and professional sports do not).
If you have remaining gain above the QSBS exclusion threshold, or ineligible shares, the strategies above (exchange fund, PVF, CRT) apply to that portion.
Direct indexing — absorb realized gains from other diversification moves
If you are gradually selling down a concentrated position over multiple years, direct indexing creates a continuous stream of harvested losses in a separately managed account (SMA) that offset the gains you're realizing from the sales. The mechanics are covered in detail on the direct indexing guide, but the concentrated stock interaction is worth noting here.
Coordinated strategy example: You sell $3M of concentrated stock in year 1, generating $3M in LTCG. Your SMA manager, running an S&P 500 direct index, harvests $800K in losses from individual positions underperforming the index that year. Net taxable LTCG: $2.2M instead of $3M — saving ~$190K in federal tax (23.8% × $800K). At $30M+ scale, systematic harvesting can offset $500K–$2M+ per year in realized gains, depending on market volatility and the SMA manager's execution.
Direct indexing works best as an offset tool alongside other strategies — not as the primary diversification mechanism. It doesn't eliminate the concentrated position; it reduces the tax drag of the liquidation program you're executing.
Decision framework by situation
| Situation | Primary strategy | Secondary / complement |
|---|---|---|
| Founder pre-close, QSBS-eligible shares | §1202 QSBS exclusion first; DAF for excess if philanthropic | PVF for non-QSBS shares above exclusion |
| Founder post-close, low-basis public stock, no liquidity need | Exchange fund (7-yr defer) | DAF contribution + direct indexing for ongoing TLH |
| Executive with concentrated RSU/ESPP, needs liquidity | Prepaid variable forward (PVF) | Direct indexing to offset partial gain recognition |
| Inheritor with stepped-up basis (§1014) | Outright sale often optimal (minimal gain post step-up) | Estate planning focus; GRAT/dynasty trust for future appreciation |
| UHNW with philanthropic intent, wants income | CRT with appreciated stock | DAF as remainder beneficiary |
| Multiple concentrated positions across founders round | Combination: QSBS + exchange fund for non-QSBS tranche | PVF for immediate liquidity on one tranche, exchange fund for the rest |
Why coordination matters at this scale
Concentrated position management at $30M+ is not a single-advisor problem. A PVF contract involves your investment bank structuring desk, a tax attorney reviewing constructive-sale risk, your CPA modeling the multi-year gain recognition schedule, and your financial advisor coordinating the SMA offset strategy. Execute any one piece in isolation and you likely leave money on the table — or create a tax problem you didn't intend.
Common coordination failures:
- CPA runs the QSBS analysis but doesn't know the company's gross asset threshold at issuance — and the stock doesn't qualify. The client discovers this post-close.
- Banker structures a PVF; client also contributes shares to a DAF in the same tax year. Constructive sale risk isn't assessed for the combined position.
- Exchange fund manager receives the contribution. The estate plan has an irrevocable trust that was supposed to receive those shares for IDGT planning — now the transfer opportunity is gone.
- Direct indexing SMA is managed by a different firm; the harvested losses occur in a different tax year than the PVF settlement. Timing mismatch reduces the offset value.
Fee-only RIAs with UHNW experience act as the coordination layer — not drafting tax opinions or legal documents, but knowing which advisors need to be in the same room, in what sequence, and with what information. For a $50M position with multiple strategies in play, this coordination has an economic value that can exceed the advisor fee by a factor of 10x.
Related reading
Sources
- Kiplinger — 2026 capital gains tax rates: 20% top rate applies to single filers above $518,900 and MFJ filers above $583,750. Values verified April 2026.
- IRS — Net Investment Income Tax (NIIT): 3.8% on net investment income for MAGI above $200,000 (single) / $250,000 (MFJ). Not indexed for inflation. Combined top rate 23.8%.
- IRC § 721 — Nonrecognition of gain or loss on contribution to a partnership. Statutory basis for exchange fund tax deferral on contributed appreciated stock.
- Cache — Exchange fund mechanics: 7-year lockup requirement, 20% illiquid asset rule, minimum investment $500K–$5M+ (institutional); basis carryover on withdrawal. Values verified April 2026.
- The Tax Adviser (AICPA) — Variable prepaid forward contracts: Rev. Rul. 2003-7 framework, deferral mechanics, constructive sale risk under §1259, Tax Court holding on contract extension triggering gain recognition.
- IRC § 1259 — Constructive sale treatment for appreciated financial positions: when a derivative contract eliminates substantially all risk of loss and opportunity for gain.
- NPTrust — Charitable deduction limits: appreciated long-term capital gain property deductible at FMV, limited to 30% of AGI; 5-year carryforward under IRC § 170(b). Values verified April 2026.
- IRC § 1202 — QSBS exclusion as amended by OBBBA (July 2025): $15M per-issuer exclusion, tiered 3/4/5-year holding period (50/75/100%), C-corp original-issue requirement, $50M gross asset test.
Tax law changes frequently. Verify all figures and strategies with qualified tax counsel for your current tax year. OBBBA implementing regulations were still being issued as of April 2026; confirm current guidance before relying on any OBBBA-related values.
Get matched with a UHNW concentrated-stock specialist
Fee-only advisor with experience coordinating exchange funds, PVF contracts, and QSBS planning at $30M+ scale. No commission conflict. Free match.